A Proposed New FDA Drug Approval Pathway: “Conditional”

The time that is taking from the discovery, then validation through approval and the use of the new treatments for cancer is taking too long. There are a lot of experimental treatments that are promising, and the increasing advances in computer technologies and Biostatistics, are bringing the question for “Conditional Approvals” issued by the FDA.

All the oncology advances were made in the first years when there weren’t any regulations. When there was an idea, the doctors put that idea to work almost immediately by adjusting and combining the treatments until they become standardized treatments. There were a lot of types of cancer cured with these kinds of treatments.

Unfortunately, those patients that have glioblastoma or pancreatic cancers, can’t afford this way of finding the treatment or the approval of new drugs.